Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Elizabeth R Hawkins, Reena R D’Souza, Astero Klampatsa Division of Cancer Therapeutics, The Institute of Cancer Research, London, UKCorrespondence: Astero KlampatsaThoracic Oncology Immunotherapy Group, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Su...
Saved in:
Main Authors: | Hawkins ER, D'Souza RR, Klampatsa A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ebb64adc425b40b8aba3cb8d1d89150f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
by: Christopher Sloas, et al.
Published: (2021) -
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
by: Jessica Waibl Polania, et al.
Published: (2021) -
Adoptive chimeric antigen receptor T cell (CAR-T) and Treg cell-based immunotherapies: Frontier therapeutic aspects in cancers
by: Mehran Bahraini, et al.
Published: (2021) -
Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
by: Shalini K. Sureshbabu, et al.
Published: (2021)